![]() Scynexis Scynexis is engaged in drug discovery, development and manufacturing projects in various areas. | ![]() Petra Pharma Petra Pharma is a drug development company focused on therapies for serious medical conditions such as cancer and metabolic diseases. | ![]() Lixte Biotechnology Lixte Biotechnology Holdings is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. | ![]() NGM Biopharmaceuticals NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system. | ||
Founding Date | Founding Date 2000 | Founding Date 2016 | Founding Date 2006 | Founding Date 2007 | Founding Date 1924 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Jersey City, US HQ | Locations New York, US HQ | Locations East Setauket, US HQ Pasadena, US | Locations South San Francisco, US HQ | Locations Madrid, ES HQ Abidjan, CI Bremen, DE Mörfelden Walldorf, DE Milano, IT Panamá, PA Windsor, GB see more |
Employees | Employees 3636% decrease | Employees 20 | Employees 3 | Employees 18622% increase | Employees 941 |
Valuation ($) | Valuation ($) 53 m | Valuation ($) N/A | Valuation ($) 2.9 m | Valuation ($) 128.5 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $20.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $4.4m (FY, 2023) | Revenue (est.) N/A |
Net income | Net income ($8.6m) (FY, 2025) | Net income N/A | Net income ($6m) (FY, 2025) | Net income ($142.4m) (FY, 2023) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 11.5m | Total funding raised $ 48m | Total funding raised $ 1.8m | Total funding raised N/A | Total funding raised N/A |

Petra Pharma is a drug development company focused on therapies for serious medical conditions such as cancer and metabolic diseases.
View company
Lixte Biotechnology Holdings is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets.
View company
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
View companyBIAL is a pharmaceutical company that discovers, develops, and commercializes medicines.
View company